UNBELIEVABLE: Kura | History Defined

The $1.24 Billion Reason Why Kura Oncology Stock Is Up Today

Kura Oncology stock rallies as the CEO revealed another $1.24 million purchase of company shares. Wall Street continues to see massive further upside in KURA shares.

Barchart · Aug 25

Donald Trump Sparks High-Stakes Financial Mockery After Allegedly Confusing an AI Firm for a Sushi Restaurant in Up to £3.76 Million ($5M) Deal

President Trump's unexpected investment in Kura Sushi USA has sparked speculation and market reactions, highlighting potential mix-ups and broader concerns about his financial activities.

International Business Times UK · May 21

Kura Oncology Q1 Earnings Call Highlights

Kura Oncology (NASDAQ:KURA) reported $5.8 million in first-quarter net product revenue from KOMZIFTI, its first commercial product, and said the launch is showing early signs of physician uptake, broad payer coverage and use in combination regimens, according to management’s earnings call for the fi

MarketBeat · May 13

This IKEA hack turns the iconic KURA bed into the childhood den we all wanted - all you need is a sheet of MDF

The easy hack is perfect for the little one's in your life

Ideal Home · Jan 21, 2025

Biotech Buyers Beware: 3 Stocks to Avoid

The biotech industry is flourishing due to groundbreaking developments in cell and gene therapies and the rapid adoption of new technologies. However, not all biotech stocks are positioned to capitalize on the industry tailwinds. Thus, investors must beware of fundamentally weak stocks: Alpine Immune (ALPN), Kura Oncology (KURA), and Blueprint…

StockNews.com · May 2, 2024

Buy, Hold, or Sell? Analyzing 3 Biotech Stocks Investors Are Watching

Amid the use of advanced technologies, personalized medicines, demand for quality treatments and therapies, and an aging population, the biotech industry appears to be on a steady path for expansion. Given this backdrop, let’s analyze the fundamentals of Biogen (BIIB), BioNTech (BNTX), and Kura (KURA) to determine which of these…

StockNews.com · Jan 24, 2024

Kura Oncology (KURA) Offers Speculators a Profit-Scalping Opportunity

With bullish traders anticipating a quick pop in KURA stock, outside observers need to pay attention, especially because of the underlying short position.

Barchart · Jan 16, 2024

Scottish Friendly outsources customer services

Jobs set to be created in Glasgow as new partnership signed

Insider UK · May 5, 2023

The Daily Biotech Pulse: Kura Lifts Clinical Hold On Blood Cancer Trial, Intuitive Surgical Earnings, Sorrento's Omicron Antibody Treatment Effective

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga · Jan 21, 2022